NF-κB and IRF7 Pathway Activation by Epstein-Barr Virus Latent Membrane Protein 1

Noncanonical NF- B Activation by the Oncoprotein Tio Occurs Through a Nonconserved TRAF3-Binding Motif

(2013) S. J. de Jong et al.   Science Signaling

Linear ubiquitination: a newly discovered regulator of cell signalling

(2013) Eva Rieser et al.   TRENDS IN BIOCHEMICAL SCIENCES

Differences in Gastric Carcinoma Microenvironment Stratify According to EBV Infection Intensity: Implications for Possible Immune Adjuvant Therapy

(2013) Michael J. Strong et al.   PLoS Pathogens

Generation and physiological roles of linear ubiquitin chains

(2012) Henning Walczak et al.   BMC BIOLOGY

Immune Surveillance and Therapy of Lymphomas Driven by Epstein-Barr Virus Protein LMP1 in a Mouse Model

(2012) Baochun Zhang et al.   CELL

Linear ubiquitination: A novel NF-^|^kappa;B regulatory mechanism for inflammatory and immune responses by the LUBAC ubiquitin ligase complex [Review]

(2012) Fuminori Tokunaga et al.   ENDOCRINE JOURNAL

NF- B, the first quarter-century: remarkable progress and outstanding questions

(2012) M. S. Hayden et al.   GENES & DEVELOPMENT

TRAF Binding Is Required for a Distinct Subset of In Vivo B Cell Functions of the Oncoprotein LMP1

(2012) K. M. Arcipowski et al.   JOURNAL OF IMMUNOLOGY

Epstein-Barr Virus Latent Membrane Protein 1 Regulates the Function of Interferon Regulatory Factor 7 by Inducing Its Sumoylation

(2012) G. L. Bentz et al.   JOURNAL OF VIROLOGY

Epstein-Barr Virus-Encoded Latent Membrane Protein 1 (LMP1) and LMP2A Function Cooperatively To Promote Carcinoma Development in a Mouse Carcinogenesis Model

(2012) K. H. Y. Shair et al.   JOURNAL OF VIROLOGY

The Epstein-Barr Virus (EBV)-Induced Tumor Suppressor MicroRNA MiR-34a Is Growth Promoting in EBV-Infected B Cells

(2012) E. Forte et al.   JOURNAL OF VIROLOGY

Contribution of a TANK-Binding Kinase 1-Interferon (IFN) Regulatory Factor 7 Pathway to IFN- -Induced Gene Expression

(2012) M. Farlik et al.   MOLECULAR AND CELLULAR BIOLOGY

Immunodeficiency, autoinflammation and amylopectinosis in humans with inherited HOIL-1 and LUBAC deficiency

(2012) Bertrand Boisson et al.   NATURE IMMUNOLOGY

Genetic Diversity of EBV-Encoded LMP1 in the Swiss HIV Cohort Study and Implication for NF-Κb Activation

(2012) Emilie Zuercher et al.   PLoS One

Genome-wide siRNA screen for mediators of NF- B activation

(2012) B. E. Gewurz et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Familial and large-scale case–control studies identify genes associated with nasopharyngeal carcinoma

(2012) Jin-Xin Bei et al.   SEMINARS IN CANCER BIOLOGY

The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC)

(2012) Christopher W. Dawson et al.   SEMINARS IN CANCER BIOLOGY

Diverse ubiquitin signaling in NF-κB activation

(2012) Kazuhiro Iwai   TRENDS IN CELL BIOLOGY

Transcriptome Changes Induced by Epstein-Barr Virus LMP1 and LMP2A in Transgenic Lymphocytes and Lymphoma

(2012) K. H. Y. Shair et al.   mBio

Novel mechanisms of EBV-induced oncogenesis

(2012) Nancy Raab-Traub   Current Opinion in Virology

The Germinal Center Kinase TNIK Is Required for Canonical NF-κB and JNK Signaling in B-Cells by the EBV Oncoprotein LMP1 and the CD40 Receptor

(2012) Anna Shkoda et al.   PLOS BIOLOGY

Viral miRNAs exploiting the endosomal–exosomal pathway for intercellular cross-talk and immune evasion

(2011) D. Michiel Pegtel et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Gammaherpesvirus and lymphoproliferative disorders in immunocompromised patients

(2011) Ethel Cesarman   CANCER LETTERS

IKK  and NF- B Transcription Govern Lymphoma Cell Survival through AKT-Induced Plasma Membrane Trafficking of GLUT1

(2011) T. G. Sommermann et al.   CANCER RESEARCH

LMP1 association with CD63 in endosomes and secretion via exosomes limits constitutive NF-κB activation

(2011) Frederik J Verweij et al.   EMBO JOURNAL

IRF7: activation, regulation, modification and function

(2011) S Ning et al.   GENES AND IMMUNITY

Epstein-Barr Virus Latent Membrane Protein 1 (LMP1) C-Terminal-Activating Region 3 Contributes to LMP1-Mediated Cellular Migration via Its Interaction with Ubc9

(2011) G. L. Bentz et al.   JOURNAL OF VIROLOGY

Microvesicles and Viral Infection

(2011) D. G. Meckes et al.   JOURNAL OF VIROLOGY

Canonical NF- B Activation Is Essential for Epstein-Barr Virus Latent Membrane Protein 1 TES2/CTAR2 Gene Regulation

(2011) B. E. Gewurz et al.   JOURNAL OF VIROLOGY

The role of microRNAs in Epstein-Barr virus latency and lytic reactivation

(2011) Eleonora Forte et al.   MICROBES AND INFECTION

Epstein-Barr Virus-Positive Diffuse Large B-Cell Lymphoma of the Elderly: What We Know So Far

(2011) J. J. Castillo et al.   ONCOLOGIST

HOIL-1L Interacting Protein (HOIP) Is Essential for CD40 Signaling

(2011) Bruce S. Hostager et al.   PLoS One

Non-canonical NF-κB signaling pathway

(2010) Shao-Cong Sun   CELL RESEARCH

Maintaining Cell Identity through Global Control of Genomic Organization

(2010) Gioacchino Natoli   IMMUNITY

An Atypical E3 Ligase Zinc Finger Protein 91 Stabilizes and Activates NF-κB-inducing Kinase via Lys63-linked Ubiquitination

(2010) Xuejun Jin et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Epstein-Barr Virus Latent Membrane Protein 1 Modulates Distinctive NF- B Pathways through C-Terminus-Activating Region 1 To Regulate Epidermal Growth Factor Receptor Expression

(2010) C.-P. Kung et al.   JOURNAL OF VIROLOGY

The A20 Deubiquitinase Activity Negatively Regulates LMP1 Activation of IRF7

(2010) S. Ning et al.   JOURNAL OF VIROLOGY

Human tumor virus utilizes exosomes for intercellular communication

(2010) D. G. Meckes et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Epstein-Barr latent membrane protein 1 transformation site 2 activates NF- B in the absence of NF- B essential modifier residues 133-224 or 373-419

(2010) D. Boehm et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Roles of TRAF2 and TRAF3 in Epstein-Barr virus latent membrane protein 1-induced alternative NF-κB activation

(2010) Yoon-Jae Song et al.   VIRUS GENES

Dynamic Evolution of Immune System Regulators: The History of the Interferon Regulatory Factor Family

(2009) J. Nehyba et al.   MOLECULAR BIOLOGY AND EVOLUTION

Zc3h12a is an RNase essential for controlling immune responses by regulating mRNA decay

(2009) Kazufumi Matsushita et al.   NATURE

Activation of innate immune antiviral responses by Nod2

(2009) Ahmed Sabbah et al.   NATURE IMMUNOLOGY

Epstein-Barr virus-encoded LMP1 induces a hyperproliferative and inflammatory gene expression programme in cultured keratinocytes

(2008) M. A. Morris et al.   JOURNAL OF GENERAL VIROLOGY

The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype

(2008) M Vockerodt et al.   JOURNAL OF PATHOLOGY

TRAF6 and the Three C-Terminal Lysine Sites on IRF7 Are Required for Its Ubiquitination-Mediated Activation by the Tumor Necrosis Factor Receptor Family Member Latent Membrane Protein 1

(2008) S. Ning et al.   MOLECULAR AND CELLULAR BIOLOGY

Nonredundant and complementary functions of TRAF2 and TRAF3 in a ubiquitination cascade that activates NIK-dependent alternative NF-κB signaling

(2008) Sivakumar Vallabhapurapu et al.   NATURE IMMUNOLOGY

IRF7 activation by Epstein-Barr virus latent membrane protein 1 requires localization at activation sites and TRAF6, but not TRAF2 or TRAF3

(2008) Y.-J. Song et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Viral Oncoprotein LMP1 Exploits TRADD for Signaling by Masking Its Apoptotic Activity

(2008) Frank Schneider et al.   PLOS BIOLOGY